Autoinjectors Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others), By Design (Standardized v/s Customized), By Product (Prefilled v/s Fillable), By Technology (Automated v/s Manual), By Type (Disposable v/s Reusable), By Route of Administration (Intravenous v/
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationAutoinjectors Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others), By Design (Standardized v/s Customized), By Product (Prefilled v/s Fillable), By Technology (Automated v/s Manual), By Type (Disposable v/s Reusable), By Route of Administration (Intravenous v/
Global autoinjectors market is anticipated to grow at an impressive growth in the next five years owing to its growth to factors like rising incidence of anaphylaxis, growing prevalence of the targeted therapies, rising initiatives from regulatory bodies. Moreover, patients in a comparatively stable state prefer self-administration of the drug, with its advantages on usability, safe and less time taking. The market observes an increasing number of regulatory approvals resulting in enhancing the feasibility of the device for the patients, and this factor is also boosting the market growth.
Autoinjectors are medical devices that are used to self-administer drugs, such as insulin, epinephrine, and other injectable medications. They are designed to be easy to use, even for people with limited medical knowledge, and provide a convenient and effective way to deliver medication. One of the key factors driving the growth of the autoinjectors market is the increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis. As the number of people suffering from these conditions continues to rise, so too does the demand for efficient and effective drug delivery methods. Autoinjectors are seen as a key solution in this area, offering patients an easy and convenient way to self-administer medication. In addition to these factors, the autoinjectors market is also being driven by technological advancements in the healthcare sector. New innovations are constantly being developed, such as autoinjectors that can be connected to mobile devices and can provide real-time data on drug usage and patient compliance. This is making it easier than ever for patients to manage their conditions and ensuring that they receive the right dose of medication at the right time.
Government support toward the favorable reimbursements and technological advancements of the device like dosage monitoring are growth-favoring factors. New players may invest in the research and development of enhanced and better versions of the devices, thereby increasing the market shares. The market also fears a minor challenge of alternate routes of drug delivery like oral administrations or nasal sprays. They pose a threat to the growth of the market, which can be overcome by technological advancements. The process of developing single design autoinjectors for multiple drugs and biologics with variable viscosities suppresses the growth of the market
Rising Incidence of chronic diseases like Anaphylaxis
For instance, according to Wiley Online Library, in 2019, the incidence of anaphylaxis in children globally, ranging from 1 to 761 per 100 000 person-years for total anaphylaxis and 1 to 77 per 100 000 person-years for food-induced anaphylaxis.
Growing Technological Advancements
For instance, in February 2021, As per the logics of thinner wall cannula technology, a US-based medical device firm namely Becton Dickinson (BD), have launch Intevia 2.25 mL. The patient-centered Intevia 2.25 mL has an 8-millimeter needle with a thinner wall and is compatible with BD Neopak XtraFlow prefill-able syringes.
Lastly, the increasing availability of generic versions of autoinjectors has made these devices more affordable and accessible to a wider range of patients. This has led to increased adoption of autoinjectors, especially in emerging markets where healthcare costs can be a significant burden.
Complexity in Developing Auto-injectors for Multiple Drugs
The different type of drugs has different viscosities, drugs with different viscosity require springs with different physical characteristics such as composition, length and thickness to create spring rate that provides enough power to push higher viscosity drugs and biologics through the syringe to the needle. In the present scenario, most of the market players are trying to develop the device with required characteristics. The companies are focusing on extensive research and developments activities to stay competitive which is considered as a big factor of suppressing the growth of global autoinjectors market.
Market Segmentation
The global autoinjector market is segmented by therapy, design, product, technology, type, route of administration, end-user, regional distribution, and competitional landscape. Based on therapy, the market is further segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and others. Based on design, the market is further segmented into standardized, customized. Based on product, the market is further segmented into prefilled, fillable. Based on technology, the market is further segmented into automated, manual. Based on type, the market is further segmented into disposable, reusable. Based on route of administration, the market is further segmented into intravenous, subcutaneous. Based on end user, the market is further segmented into hospitals & clinics, ambulatory care settings, home care settings.
Company Profiles
Mylan N.V., AbbVie Inc., Eli Lilly and Company, Ypsomed Holding AG, Amgen Inc., Becton, Dickinson, and Company, GlaxoSmithKline plc, Johnson & Johnson International, Inc., Teva Pharmaceutical Industries Ltd., Antares Pharma, Inc., Merck KGaA, F. Hoffmann-LA Roche, Bayer AG, Bristol-Myers Squibb Company, Medeca Pharma AB, etc., are some of the key players operating in the global atherectomy devices market.
| Attribute | Details |
| Base Year | 2022 |
| Historical Years | 2018 – 2022 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | · Therapy · Design · Product · Technology · Type · Route of Administration · End User · Region · Company |
| Regional Scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country Scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; UAE; Saudi Arabia; South Africa; Kuwait |
| Key Companies Profiled | Mylan N.V., AbbVie Inc., Eli Lilly and Company, Ypsomed Holding AG, Amgen Inc., Becton, Dickinson, and Company, GlaxoSmithKline plc, Johnson & Johnson International, Inc., Teva Pharmaceutical Industries Ltd., Antares Pharma, Inc., Merck KGaA, F. Hoffmann-LA Roche, Bayer AG, Bristol-Myers Squibb Company, Medeca Pharma AB. |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy